ArticleHemaSphere2026

Clinical impact of immunoglobulin heavy chain repertoire in mantle cell lymphoma: A study from the Fondazione Italiana Linfomi (FIL) Phase III MCL0208 trial.

Simone Ragaini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.